OrbiMed’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-117,000
Closed -$2.23M 123
2023
Q4
$2.23M Buy
+117,000
New +$2.23M 0.04% 94
2022
Q4
Sell
-303,000
Closed -$7.93K 128
2022
Q3
$7.93K Buy
+303,000
New +$7.93K 0.15% 91
2020
Q3
Sell
-220,350
Closed -$5.45M 152
2020
Q2
$5.45M Buy
+220,350
New +$5.45M 0.08% 116